Vir Biotechnology Inc (VIR)
7.34
-0.03
(-0.41%)
USD |
NASDAQ |
Dec 20, 16:00
7.24
-0.10
(-1.36%)
After-Hours: 20:00
Vir Biotechnology Enterprise Value: 96.39M for Dec. 20, 2024
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Janux Therapeutics Inc | 2.318B |
| Biomarin Pharmaceutical Inc | 12.18B |
| Arbutus Biopharma Corp | 480.47M |
| GlycoMimetics Inc | 0.6782M |
| FibroGen Inc | 24.05M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -213.72M |
| Revenue (Quarterly) | 0.289M |
| Total Expenses (Quarterly) | 218.88M |
| EPS Diluted (Quarterly) | -1.56 |
| Gross Profit Margin (Quarterly) | 82.70% |
| Profit Margin (Quarterly) | -73.95K% |
| Earnings Yield | -53.41% |
| Normalized Earnings Yield | -50.22 |